- Title
- A randomized placebo-controlled trial of saracatinib (AZD0530) plus weekly paclitaxel in platinum-resistant ovarian, fallopian-tube, or primary peritoneal cancer (SaPPrOC)
- Creators
- IA McNeishJA LedermannLC WebberLE JamesSB KayeGJS RustinG HallA ClampHM EarlSN BanerjeeRS KristeleitF RajaA FeeneyC LawrenceL Dawson-AtheyM PersicI Khan
- Contributors
- AMER SOC CLINICAL ONCOLOGY (Publisher)
- Publication Details
- JOURNAL OF CLINICAL ONCOLOGY, Vol.31(15)
- Conference
- Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO) (Chicago, IL, 31/05/2013 - 04/06/2013)
- Date published
- 20/05/2013
- Date submitted
- 17/05/2017
- Identifiers
- 99511541502346
- Academic Unit
- University of Surrey
- Resource Type
- Conference presentation
Conference presentation
A randomized placebo-controlled trial of saracatinib (AZD0530) plus weekly paclitaxel in platinum-resistant ovarian, fallopian-tube, or primary peritoneal cancer (SaPPrOC)
JOURNAL OF CLINICAL ONCOLOGY, Vol.31(15)
Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO) (Chicago, IL, 31/05/2013 - 04/06/2013)
20/05/2013
Metrics
29 Record Views